Characterization of anxiety-related responses in male rats following prolonged exposure to therapeutic doses of oral methylphenidate

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 4, 2009, Pages 451-459

  Britton, Gabrielle B ^a,b   Bethancourt, José A ^a  

^a INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^b Clínica Neuropsicológica   (Panama)

Author keywords

Anxiety; Behavior test battery; Methylphenidate; Rat; Ritalin

Indexed keywords

METHYLPHENIDATE;

ADULT ANIMAL; ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG USE; FEAR; LIGHT DARK CYCLE; MALE; MAZE TEST; NERVE CELL NETWORK; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; TREATMENT DURATION; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANXIETY; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DARKNESS; EMOTIONS; EXPLORATORY BEHAVIOR; FEAR; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 68049100109     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.06.007     Document Type: Article

References (48)

1. Anderson S.L. Stimulants and the developing brain. Trends Pharmacol Sci 26 (2005) 237-243
2. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121 (1997) 65-94
3. Bethancourt J.A., Camarena Z.Z., and Britton G.B. Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory. Behav Brain Res 202 (2009) 50-57
4. Biederman J., and Faraone S. Attention deficit hyperactivity disorder. Lancet 366 (2005) 237-248
5. Bolaños C.A., Glatt S.J., and Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Res Dev Brain Res 111 (1998) 25-33
6. Bolaños C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54 (2003) 1317-1329
7. Bouton M.E., and Bolles R.C. Conditioned fear assessed by freezing and by the suppression of three different baselines. Anim Learn Behav 8 (1980) 429-434
8. Brandon C.L., Marinelli M., and White F.J. Adolescent exposure to methylphenidate alters activity of rat midbrain dopamine neurons. Biol Psychiatry 54 (2003) 1338-1344
9. Britton G.B., and Astheimer L.B. Fear develops to the conditioned stimulus and to the context during classical eyeblink conditioning in rats. Integr Phys Behav Sci 39 (2004) 295-306
10. Britton G.B., Segan A.T., Sejour J., and Mancebo S. Early exposure to methylphenidate increases fear responses in an aversive context in adult rats. Dev Psychobiol 49 (2007) 265-275
11. Carlezon W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54 (2003) 1330-1337
12. Chuhan Y.S., and Taukulis H.K. Impairment of single-trial memory formation by oral methylphenidate in the rat. Neurobiol Learn Mem 85 (2006) 125-131
13. Deacon R.M.J. Housing, husbandry and handling of rodents for behavioral experiments. Nat Protoc 1 (2006) 936-946
14. Dommett E.J., Henderson E.L., Westwell M.S., and Greenfield S.A. Methylphenidate amplifies plasticity in the hippocampus via noradrenergic mechanisms. Learn Mem 15 (2008) 580-586
15. Fanselow M.S. Conditional and unconditional components of post-shock freezing. Pav J Biol Sci 15 (1980) 177-182
16. Fanselow M.S. The postshock activity burst. Anim Learn Behav 10 (1982) 448-454
17. Fanselow M.S. Factors governing one trial contextual conditioning. Anim Learn Behav 18 (1990) 264-270
18. Faraone S.V., Biederman J., Spencer T., Wilens T., Seidman L.J., Mick E., et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48 (2000) 9-20
19. File S.E. Animal models of different anxiety states. Adv Biochem Psychopharmacol 48 (1995) 93-113
20. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 295 (2000) 51-57
21. Giedd J.N., Rosenthal M.A., Blythe R.A., Blumenthal J.D., Molloy E., Dopp R.R., et al. Brain development in healthy children and adolescents: magnetic resonance imaging studies. In: Keshavan M.S., Kennedy J.L., and Murray R.M. (Eds). Neurodevelopment and schizophrenia (2004), University Press, NY 35-44
22. Gray J.R. Integration of emotion and cognitive control. Curr Dir Psychol Sci 13 (2004) 46-48
23. Gray J.D., Punsoni M., Tabori N.E., Melton J.T., Fanslow V., Ward M.J., et al. Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. J Neurosci 27 (2007) 7196-7207
24. Henderson N.D., Turri M.G., DeFries J.C., and Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet 34 (2004) 267-293
25. Kuczenski R., and Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22 (2002) 7264-7271
26. Kuczenski R., and Segal D.S. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential for substance abuse. Biol Psychiatry 57 (2005) 1391-1396
27. LeBlanc-Duchin D., and Taukulis H.K. Behavioral reactivity to a noradrenergic challenge after chronic oral methylphenidate (Ritalin) in rats. Pharmacol Biochem Behav 79 (2004) 641-649
28. LeBlanc-Duchin D., and Taukulis H.K. Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. Neurobiol Learn Mem 88 (2007) 312-320
29. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacol (Berlin) 102 (1987) 507-513
30. McIlwain K.L., Merriweather M.Y., Yuva-Paylor L.A., and Paylor R. The use of behavioral test batteries: effects of training history. Physiol Behav 73 (2001) 705-717
31. Moll G.H., Hause S., Rüther E., Rothenberger A., and Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol 11 (2001) 15-24
32. Pastor P.N., and Reuben C.A. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. National Center for Health Statistics. Vital Health Stat 10 (2008) 237
33. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
34. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol (2004) 301-320
35. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106 (1992) 274-285
36. Pietrzak R.H., Mollica C.M., Maruff P., and Snyder P. Cognitive effects of immediate release methylphenidate in children with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 30 (2006) 1225-1245
37. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94 (1998) 127-152
38. Spear L.P. The adolescent brain and age-related behavioral manisfestations. Neurosci Biobehav Rev 24 (2000) 417-463
39. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., and Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Psych 35 (1996) 409-432
40. Swanson J.M., and Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 27 (2003) 615-621
41. Swanson J.M., Sergeant J., Taylor E., Sonuga-Barke E.J.S., Jensen P., and Cantwell D. Attention deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
42. Thanos P.K., Michaelides M., Benveniste H., Wang G.J., and Volkow N.D. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharm Biochem Behav 87 (2007) 426-433
43. Volkow N.D., and Insel T.R. What are the long-term effects of methylphenidate treatment?. Biol Psychiatry 54 (2003) 1307-1309
44. Wheeler T.L., Eppolito A.K., Smith L.N., Huff T.B., and Smith R.F. A novel method for oral stimulant administration in the neonate rat and similar species. J Neurosci Methods 159 (2007) 282-285
45. Wilens T.E., Biederman J., and Spencer T.J. Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53 (2002) 113-131
46. Yang P.B., Swann A.C., and Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res 1145 (2007) 66-80
47. Zeise M.L., Espinoza S., González A., Cerda F.S., Nacarate J., Yáñez C.G., et al. Methylphenidate improves cue navigation in the Morris water maze in rats. NeuroReport 18 (2007) 1059-1062
48. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., and Lynch F. Trends in prescribing of psychotropic medications to preschoolers. J Am Med Assoc 283 (2000) 1025-1030